Nanofibres in drug delivery / / Gareth R. Williams [and three others].
In recent years there has been an explosion of interest in the production of nanoscale fibres for drug delivery and tissue engineering. Nanofibres in Drug Delivery aims to outline to new researchers in the field the utility of nanofibres in drug delivery, and to explain to them how to prepare fibres...
Saved in:
VerfasserIn: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | London : : University College London,, 2018. |
Year of Publication: | 2018 |
Language: | English |
Physical Description: | 1 online resource (242 pages) :; illustrations (some color) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993655378304498 |
---|---|
ctrlnum |
(CKB)4100000009934211 (NjHacI)994100000009934211 (EXLCZ)994100000009934211 |
collection |
bib_alma |
record_format |
marc |
spelling |
Williams, Gareth R., author. Nanofibres in drug delivery / Gareth R. Williams [and three others]. UCL Press 2018 London : University College London, 2018. 1 online resource (242 pages) : illustrations (some color) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. In recent years there has been an explosion of interest in the production of nanoscale fibres for drug delivery and tissue engineering. Nanofibres in Drug Delivery aims to outline to new researchers in the field the utility of nanofibres in drug delivery, and to explain to them how to prepare fibres in the laboratory. The book begins with a brief discussion of the main concepts in pharmaceutical science. The authors then introduce the key techniques that can be used for fibre production and explain briefly the theory behind them. They discuss the experimental implementation of fibre production, starting with the simplest possible set-up and then moving on to consider more complex arrangements. As they do so, they offer advice from their own experience of fibre production, and use examples from current literature to show how each particular type of fibre can be applied to drug delivery. They also consider how fibre production could be moved beyond the research laboratory into industry, discussing regulatory and scale-up aspects. Intro; Half Title; Title Page; Copyright Page; Acknowledgements; Contents; List of figures; List of abbreviations; 1 Introduction; 1.1 Preamble; 1.2 Nanofibres; 1.3 Key concepts in drug delivery; 1.3.1 The therapeutic window and bioavailability; 1.3.2 Modified-release systems; 1.3.3 Dissolution, solubility and permeability; 1.3.4 Physical form; 1.4 Nanofibre characterisation; 1.4.1 Electron microscopy; 1.4.2 X-ray diffraction; 1.4.3 Thermal methods; 1.4.4 Infrared spectroscopy; 1.4.5 Functional performance; 1.4.5.1 Dissolution and permeability testing; 1.4.5.2 API quantification 1.4.6 Stability studies1.5 An overview of contemporary pharmaceutical technology; 1.5.1 Hot melt extrusion; 1.5.2 Spray drying; 1.5.3 Freeze drying; 1.5.4 Nanofibre manufacturing; 1.6 Summary; References; 2 Electrospinning fundamentals; 2.1 Background; 2.2 A brief history of electrospinning; 2.3 EHD fundamentals; 2.4 Understanding the electrospinning process; 2.4.1 Jet initiation; 2.4.2 Electrospinning vs. electrospraying; 2.4.3 Jet elongation: bending and whipping; 2.4.4 Jet solidification; 2.5 The parameters affecting electrospinning; 2.5.1 Solution parameters; 2.5.2 Processing parameters 2.5.3 Environmental parameters2.5.4 Solvent and polymer selection; 2.6 The experimental set-up; 2.6.1 Basics; 2.6.2 The power supply and syringe pump; 2.6.3 The spinneret; 2.6.4 The collector; 2.6.5 Other considerations; 2.6.6 Establishing and troubleshooting an electrospinning process; 2.7 Fibre properties; 2.8 Characterisation; 2.9 Summary; References; 3 Monoaxial electrospinning; 3.1 Introduction; 3.2 Experimental considerations; 3.2.1 Solution parameters; 3.2.2 Processing parameters; 3.2.3 The spinneret; 3.2.4 Polymer choice; 3.2.5 Starting experimental work; 3.3 Fibre properties 3.4 Some typical results3.5 Fast-dissolving drug delivery systems; 3.5.1 Electrospun fast-dissolving drug delivery systems; 3.5.2 Caveats; 3.5.3 Multicomponent formulations; 3.5.4 Stability; 3.6 Extended-release systems; 3.6.1 Applications; 3.6.2 Drawbacks and release mechanisms; 3.7 pH-controlled delivery; 3.7.1 Oral administration; 3.7.2 Anticancer applications; 3.8 Pulsatile release; 3.9 Multilayer materials; 3.10 Thermoresponsive systems; 3.11 Emulsion and suspension electrospinning; 3.11.1 Emulsions; 3.11.2 Suspensions; 3.12 Tissue-engineering applications 3.13 Using fibres as sacrificial templates3.14 Conclusions; References; 4 Coaxial and multi-axial electrospinning; 4.1 Introduction; 4.2 Experimental considerations; 4.2.1 Handling two liquids; 4.2.2 The spinneret and electrodes; 4.2.3 Establishing a coaxial process; 4.3 Extended-release systems; 4.3.1 Preventing burst release; 4.3.2 Biphasic release; 4.4 Targeted drug delivery; 4.5 Multifunctional materials; 4.6 Other applications; 4.7 Protein delivery systems; 4.8 Cell electrospinning; 4.9 Modified coaxial spinning; 4.10 Triaxial and quad-axial systems; 4.11 Conclusions; References. English Nanofibers. Drug delivery devices. Nanofibres Drugs Drug delivery Luo, C. J., author. Raimi-Abraham, Bahijja T., author. 1-78735-021-5 1-78735-023-1 |
language |
English |
format |
eBook |
author |
Williams, Gareth R., Luo, C. J., Raimi-Abraham, Bahijja T., |
spellingShingle |
Williams, Gareth R., Luo, C. J., Raimi-Abraham, Bahijja T., Nanofibres in drug delivery / Intro; Half Title; Title Page; Copyright Page; Acknowledgements; Contents; List of figures; List of abbreviations; 1 Introduction; 1.1 Preamble; 1.2 Nanofibres; 1.3 Key concepts in drug delivery; 1.3.1 The therapeutic window and bioavailability; 1.3.2 Modified-release systems; 1.3.3 Dissolution, solubility and permeability; 1.3.4 Physical form; 1.4 Nanofibre characterisation; 1.4.1 Electron microscopy; 1.4.2 X-ray diffraction; 1.4.3 Thermal methods; 1.4.4 Infrared spectroscopy; 1.4.5 Functional performance; 1.4.5.1 Dissolution and permeability testing; 1.4.5.2 API quantification 1.4.6 Stability studies1.5 An overview of contemporary pharmaceutical technology; 1.5.1 Hot melt extrusion; 1.5.2 Spray drying; 1.5.3 Freeze drying; 1.5.4 Nanofibre manufacturing; 1.6 Summary; References; 2 Electrospinning fundamentals; 2.1 Background; 2.2 A brief history of electrospinning; 2.3 EHD fundamentals; 2.4 Understanding the electrospinning process; 2.4.1 Jet initiation; 2.4.2 Electrospinning vs. electrospraying; 2.4.3 Jet elongation: bending and whipping; 2.4.4 Jet solidification; 2.5 The parameters affecting electrospinning; 2.5.1 Solution parameters; 2.5.2 Processing parameters 2.5.3 Environmental parameters2.5.4 Solvent and polymer selection; 2.6 The experimental set-up; 2.6.1 Basics; 2.6.2 The power supply and syringe pump; 2.6.3 The spinneret; 2.6.4 The collector; 2.6.5 Other considerations; 2.6.6 Establishing and troubleshooting an electrospinning process; 2.7 Fibre properties; 2.8 Characterisation; 2.9 Summary; References; 3 Monoaxial electrospinning; 3.1 Introduction; 3.2 Experimental considerations; 3.2.1 Solution parameters; 3.2.2 Processing parameters; 3.2.3 The spinneret; 3.2.4 Polymer choice; 3.2.5 Starting experimental work; 3.3 Fibre properties 3.4 Some typical results3.5 Fast-dissolving drug delivery systems; 3.5.1 Electrospun fast-dissolving drug delivery systems; 3.5.2 Caveats; 3.5.3 Multicomponent formulations; 3.5.4 Stability; 3.6 Extended-release systems; 3.6.1 Applications; 3.6.2 Drawbacks and release mechanisms; 3.7 pH-controlled delivery; 3.7.1 Oral administration; 3.7.2 Anticancer applications; 3.8 Pulsatile release; 3.9 Multilayer materials; 3.10 Thermoresponsive systems; 3.11 Emulsion and suspension electrospinning; 3.11.1 Emulsions; 3.11.2 Suspensions; 3.12 Tissue-engineering applications 3.13 Using fibres as sacrificial templates3.14 Conclusions; References; 4 Coaxial and multi-axial electrospinning; 4.1 Introduction; 4.2 Experimental considerations; 4.2.1 Handling two liquids; 4.2.2 The spinneret and electrodes; 4.2.3 Establishing a coaxial process; 4.3 Extended-release systems; 4.3.1 Preventing burst release; 4.3.2 Biphasic release; 4.4 Targeted drug delivery; 4.5 Multifunctional materials; 4.6 Other applications; 4.7 Protein delivery systems; 4.8 Cell electrospinning; 4.9 Modified coaxial spinning; 4.10 Triaxial and quad-axial systems; 4.11 Conclusions; References. |
author_facet |
Williams, Gareth R., Luo, C. J., Raimi-Abraham, Bahijja T., Luo, C. J., Raimi-Abraham, Bahijja T., |
author_variant |
g r w gr grw c j l cj cjl b t r a btr btra |
author_role |
VerfasserIn VerfasserIn VerfasserIn |
author2 |
Luo, C. J., Raimi-Abraham, Bahijja T., |
author2_role |
TeilnehmendeR TeilnehmendeR |
author_sort |
Williams, Gareth R., |
title |
Nanofibres in drug delivery / |
title_full |
Nanofibres in drug delivery / Gareth R. Williams [and three others]. |
title_fullStr |
Nanofibres in drug delivery / Gareth R. Williams [and three others]. |
title_full_unstemmed |
Nanofibres in drug delivery / Gareth R. Williams [and three others]. |
title_auth |
Nanofibres in drug delivery / |
title_new |
Nanofibres in drug delivery / |
title_sort |
nanofibres in drug delivery / |
publisher |
UCL Press University College London, |
publishDate |
2018 |
physical |
1 online resource (242 pages) : illustrations (some color) |
contents |
Intro; Half Title; Title Page; Copyright Page; Acknowledgements; Contents; List of figures; List of abbreviations; 1 Introduction; 1.1 Preamble; 1.2 Nanofibres; 1.3 Key concepts in drug delivery; 1.3.1 The therapeutic window and bioavailability; 1.3.2 Modified-release systems; 1.3.3 Dissolution, solubility and permeability; 1.3.4 Physical form; 1.4 Nanofibre characterisation; 1.4.1 Electron microscopy; 1.4.2 X-ray diffraction; 1.4.3 Thermal methods; 1.4.4 Infrared spectroscopy; 1.4.5 Functional performance; 1.4.5.1 Dissolution and permeability testing; 1.4.5.2 API quantification 1.4.6 Stability studies1.5 An overview of contemporary pharmaceutical technology; 1.5.1 Hot melt extrusion; 1.5.2 Spray drying; 1.5.3 Freeze drying; 1.5.4 Nanofibre manufacturing; 1.6 Summary; References; 2 Electrospinning fundamentals; 2.1 Background; 2.2 A brief history of electrospinning; 2.3 EHD fundamentals; 2.4 Understanding the electrospinning process; 2.4.1 Jet initiation; 2.4.2 Electrospinning vs. electrospraying; 2.4.3 Jet elongation: bending and whipping; 2.4.4 Jet solidification; 2.5 The parameters affecting electrospinning; 2.5.1 Solution parameters; 2.5.2 Processing parameters 2.5.3 Environmental parameters2.5.4 Solvent and polymer selection; 2.6 The experimental set-up; 2.6.1 Basics; 2.6.2 The power supply and syringe pump; 2.6.3 The spinneret; 2.6.4 The collector; 2.6.5 Other considerations; 2.6.6 Establishing and troubleshooting an electrospinning process; 2.7 Fibre properties; 2.8 Characterisation; 2.9 Summary; References; 3 Monoaxial electrospinning; 3.1 Introduction; 3.2 Experimental considerations; 3.2.1 Solution parameters; 3.2.2 Processing parameters; 3.2.3 The spinneret; 3.2.4 Polymer choice; 3.2.5 Starting experimental work; 3.3 Fibre properties 3.4 Some typical results3.5 Fast-dissolving drug delivery systems; 3.5.1 Electrospun fast-dissolving drug delivery systems; 3.5.2 Caveats; 3.5.3 Multicomponent formulations; 3.5.4 Stability; 3.6 Extended-release systems; 3.6.1 Applications; 3.6.2 Drawbacks and release mechanisms; 3.7 pH-controlled delivery; 3.7.1 Oral administration; 3.7.2 Anticancer applications; 3.8 Pulsatile release; 3.9 Multilayer materials; 3.10 Thermoresponsive systems; 3.11 Emulsion and suspension electrospinning; 3.11.1 Emulsions; 3.11.2 Suspensions; 3.12 Tissue-engineering applications 3.13 Using fibres as sacrificial templates3.14 Conclusions; References; 4 Coaxial and multi-axial electrospinning; 4.1 Introduction; 4.2 Experimental considerations; 4.2.1 Handling two liquids; 4.2.2 The spinneret and electrodes; 4.2.3 Establishing a coaxial process; 4.3 Extended-release systems; 4.3.1 Preventing burst release; 4.3.2 Biphasic release; 4.4 Targeted drug delivery; 4.5 Multifunctional materials; 4.6 Other applications; 4.7 Protein delivery systems; 4.8 Cell electrospinning; 4.9 Modified coaxial spinning; 4.10 Triaxial and quad-axial systems; 4.11 Conclusions; References. |
isbn |
1-78735-022-3 9781787350180 1-78735-018-5 1-78735-019-3 1-78735-021-5 1-78735-023-1 |
callnumber-first |
T - Technology |
callnumber-subject |
TA - General and Civil Engineering |
callnumber-label |
TA418 |
callnumber-sort |
TA 3418.9 F5 W555 42018 |
illustrated |
Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
620 - Engineering |
dewey-ones |
620 - Engineering & allied operations |
dewey-full |
620.5 |
dewey-sort |
3620.5 |
dewey-raw |
620.5 |
dewey-search |
620.5 |
work_keys_str_mv |
AT williamsgarethr nanofibresindrugdelivery AT luocj nanofibresindrugdelivery AT raimiabrahambahijjat nanofibresindrugdelivery |
status_str |
n |
ids_txt_mv |
(CKB)4100000009934211 (NjHacI)994100000009934211 (EXLCZ)994100000009934211 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Nanofibres in drug delivery / |
author2_original_writing_str_mv |
noLinkedField noLinkedField |
_version_ |
1803964318851530752 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05534nam a2200529 i 4500</leader><controlfield tag="001">993655378304498</controlfield><controlfield tag="005">20240310132727.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221224s2018 enka o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-78735-022-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781787350180</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-78735-018-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-78735-019-3</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.14324/111.9781787350182</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000009934211</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994100000009934211</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000009934211</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="042" ind1=" " ind2=" "><subfield code="a">dc</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">TA418.9.F5</subfield><subfield code="b">.W555 2018</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">KNDP</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MM</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MMZ</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">620.5</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Williams, Gareth R.,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nanofibres in drug delivery /</subfield><subfield code="c">Gareth R. Williams [and three others].</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">UCL Press</subfield><subfield code="c">2018</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London :</subfield><subfield code="b">University College London,</subfield><subfield code="c">2018.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (242 pages) :</subfield><subfield code="b">illustrations (some color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In recent years there has been an explosion of interest in the production of nanoscale fibres for drug delivery and tissue engineering. Nanofibres in Drug Delivery aims to outline to new researchers in the field the utility of nanofibres in drug delivery, and to explain to them how to prepare fibres in the laboratory. The book begins with a brief discussion of the main concepts in pharmaceutical science. The authors then introduce the key techniques that can be used for fibre production and explain briefly the theory behind them. They discuss the experimental implementation of fibre production, starting with the simplest possible set-up and then moving on to consider more complex arrangements. As they do so, they offer advice from their own experience of fibre production, and use examples from current literature to show how each particular type of fibre can be applied to drug delivery. They also consider how fibre production could be moved beyond the research laboratory into industry, discussing regulatory and scale-up aspects.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Intro; Half Title; Title Page; Copyright Page; Acknowledgements; Contents; List of figures; List of abbreviations; 1 Introduction; 1.1 Preamble; 1.2 Nanofibres; 1.3 Key concepts in drug delivery; 1.3.1 The therapeutic window and bioavailability; 1.3.2 Modified-release systems; 1.3.3 Dissolution, solubility and permeability; 1.3.4 Physical form; 1.4 Nanofibre characterisation; 1.4.1 Electron microscopy; 1.4.2 X-ray diffraction; 1.4.3 Thermal methods; 1.4.4 Infrared spectroscopy; 1.4.5 Functional performance; 1.4.5.1 Dissolution and permeability testing; 1.4.5.2 API quantification 1.4.6 Stability studies1.5 An overview of contemporary pharmaceutical technology; 1.5.1 Hot melt extrusion; 1.5.2 Spray drying; 1.5.3 Freeze drying; 1.5.4 Nanofibre manufacturing; 1.6 Summary; References; 2 Electrospinning fundamentals; 2.1 Background; 2.2 A brief history of electrospinning; 2.3 EHD fundamentals; 2.4 Understanding the electrospinning process; 2.4.1 Jet initiation; 2.4.2 Electrospinning vs. electrospraying; 2.4.3 Jet elongation: bending and whipping; 2.4.4 Jet solidification; 2.5 The parameters affecting electrospinning; 2.5.1 Solution parameters; 2.5.2 Processing parameters 2.5.3 Environmental parameters2.5.4 Solvent and polymer selection; 2.6 The experimental set-up; 2.6.1 Basics; 2.6.2 The power supply and syringe pump; 2.6.3 The spinneret; 2.6.4 The collector; 2.6.5 Other considerations; 2.6.6 Establishing and troubleshooting an electrospinning process; 2.7 Fibre properties; 2.8 Characterisation; 2.9 Summary; References; 3 Monoaxial electrospinning; 3.1 Introduction; 3.2 Experimental considerations; 3.2.1 Solution parameters; 3.2.2 Processing parameters; 3.2.3 The spinneret; 3.2.4 Polymer choice; 3.2.5 Starting experimental work; 3.3 Fibre properties 3.4 Some typical results3.5 Fast-dissolving drug delivery systems; 3.5.1 Electrospun fast-dissolving drug delivery systems; 3.5.2 Caveats; 3.5.3 Multicomponent formulations; 3.5.4 Stability; 3.6 Extended-release systems; 3.6.1 Applications; 3.6.2 Drawbacks and release mechanisms; 3.7 pH-controlled delivery; 3.7.1 Oral administration; 3.7.2 Anticancer applications; 3.8 Pulsatile release; 3.9 Multilayer materials; 3.10 Thermoresponsive systems; 3.11 Emulsion and suspension electrospinning; 3.11.1 Emulsions; 3.11.2 Suspensions; 3.12 Tissue-engineering applications 3.13 Using fibres as sacrificial templates3.14 Conclusions; References; 4 Coaxial and multi-axial electrospinning; 4.1 Introduction; 4.2 Experimental considerations; 4.2.1 Handling two liquids; 4.2.2 The spinneret and electrodes; 4.2.3 Establishing a coaxial process; 4.3 Extended-release systems; 4.3.1 Preventing burst release; 4.3.2 Biphasic release; 4.4 Targeted drug delivery; 4.5 Multifunctional materials; 4.6 Other applications; 4.7 Protein delivery systems; 4.8 Cell electrospinning; 4.9 Modified coaxial spinning; 4.10 Triaxial and quad-axial systems; 4.11 Conclusions; References.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Nanofibers.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drug delivery devices.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Nanofibres</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Drugs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Drug delivery</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Luo, C. J.,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Raimi-Abraham, Bahijja T.,</subfield><subfield code="e">author.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-78735-021-5</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-78735-023-1</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2024-07-08 00:39:06 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-12-15 09:13:23 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337614250004498&Force_direct=true</subfield><subfield code="Z">5337614250004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337614250004498</subfield></datafield></record></collection> |